Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impulse control disorders in Parkinson's disease.

Daniel Weintraub1, Marc N Potenza

  • 1Department of Psychiatry, University of Pennsylvania, 3535 Market Street, Room 3003, Philadelphia, PA 19104, USA. weintrau@mail.med.upenn.edu

Current Neurology and Neuroscience Reports
|July 11, 2006
PubMed
Summary

Parkinson's disease (PD) patients may develop impulse control disorders (ICDs) like gambling or compulsive sexual behavior, often linked to dopamine agonist use. Management involves adjusting or stopping these medications, with ongoing research into new treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychometric Evidence for an Augmented PDAQ for Improved Measurement of Cognition-Related IADLs in Parkinson's Disease.

Movement disorders clinical practice·2026
Same author

Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.

Annals of neurology·2026
Same author

Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.

Annals of neurology·2026
Same author

Utilizing Intraindividual Cognitive Variability to Predict Early Neuronal Synuclein Disease Progression.

medRxiv : the preprint server for health sciences·2026
Same author

Genetic and Proteomic Investigation of the Smoking-Parkinson's Disease Association.

medRxiv : the preprint server for health sciences·2026
Same author

Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy.

Annals of clinical and translational neurology·2026

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Impulse control disorders (ICDs) are increasingly recognized as a complication in Parkinson's disease (PD).
  • A potential link exists between dopamine agonist therapy and the development of ICDs in PD patients.
  • Established treatments for ICDs in PD are currently lacking.

Purpose of the Study:

  • To highlight the association between dopamine agonists and ICDs in Parkinson's disease.
  • To inform clinical management strategies for PD patients experiencing ICDs.
  • To emphasize the need for patient and clinician awareness regarding this complication.

Main Methods:

  • Review of anecdotal evidence and case reports.
  • Clinical observation and experience.

Related Experiment Videos

  • Discussion of current management approaches and future research directions.

    • Main Results:

    • Dopamine agonist use is associated with an increased risk of ICDs in Parkinson's disease patients.
    • Modifying or discontinuing dopamine replacement therapy, especially dopamine agonists, is the initial management strategy.
    • Patient and clinician awareness is crucial for early detection and intervention.

    Conclusions:

    • Clinicians should monitor Parkinson's disease patients for ICDs, particularly those on dopamine agonists.
    • Adjusting dopaminergic therapy is the primary approach to managing ICDs in PD.
    • Further research is needed to develop and validate effective treatments for ICDs in this population.